South Korea Anti-Infective Drugs Market Insight
Published: 01 June 2026 | Report Format: Electronic (PDF)
South Korea anti-infective drugs market is expected to exhibit growth with a CAGR of 6.4% due to growing incidences of infections, rising fears of antimicrobial resistance, improving hospital treatment facilities.
South Korea Anti-Infective Drugs Market Insights Forecasts to 2035
- The South Korea Anti-Infective Drugs Market Size Was Estimated USD 5.48 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.4% from 2025 to 2035
- The South Korea Anti-Infective Drugs Market Size is Expected to rise around USD 10.19 Billion by 2035
Notable Insights for the South Korea Anti-Infective Drugs Market
- The Antibiotics segment accounted for approximately 49% of the South Korea Anti-Infective Drugs Market share in 2025 due to increasing treatment demand for bacterial infections and rising hospital-based antimicrobial therapies.
- The Hospital Pharmacies segment represented nearly 57% market share in 2025 owing to increasing inpatient treatment volumes, critical care admissions, and infectious disease management programs across South Korea.
- The estimated global revenue generated by Pfizer Inc. exceeded USD 63 billion in 2025, supported by strong demand for anti-infective therapeutics, vaccines, and specialty pharmaceutical products.
Download the eBook (ToC)
- Growing investments in AI-driven drug discovery systems, biologics manufacturing infrastructure, and antimicrobial resistance management technologies are supporting market expansion, where advanced anti-infective therapies improve treatment effectiveness by approximately 38% and reduce infection recurrence rates by nearly 29%.
Why Buy This Report
- Provides comprehensive analysis of anti-infective drug technologies, infectious disease treatment systems, and pharmaceutical manufacturing developments influencing growth in the South Korea Anti-Infective Drugs Market.
- Offers strategic insights into emerging technologies including AI-powered antimicrobial drug discovery platforms, precision infectious disease diagnostics, biologics manufacturing systems, and next-generation antiviral therapeutic architectures.
- Supports stakeholders in evaluating competitive positioning, pharmaceutical investment strategies, infectious disease treatment developments, and advanced therapeutics innovation trends across South Korea.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Anti-Infective Drugs Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Anti-Infective Drugs Market
- Pfizer Inc.
- GSK plc
- Shionogi & Co., Ltd.
- Merck & Co., Inc.
- Sanofi S.A.
- Roche Holding AG
- Celltrion Inc.
- JW Pharmaceutical Corporation
- Chong Kun Dang Pharmaceutical Corp.
- Daewoong Pharmaceutical Co., Ltd..
Recent Developments:
- In June 2025, Shionogi & Co., Ltd. strengthened antiviral drug development initiatives and expanded collaborative infectious disease research activities across Asia-Pacific healthcare markets.
- In March 2025, Pfizer Inc. expanded infectious disease treatment research programs focused on next-generation antibacterial therapies and hospital anti-infective drug manufacturing capabilities.
Market Segmentation:
South Korea Anti-Infective Drugs Market, By Drug Type
- Antibiotics
- Antiviral Drugs
- Antifungal Drugs
- Antiparasitic Drugs
South Korea Anti-Infective Drugs Market, By Technology
- AI-Powered Drug Discovery Systems
- Precision Infectious Disease Diagnostics
- Biologics Manufacturing Technologies
- Smart Pharmaceutical Production Platforms
South Korea Anti-Infective Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Specialty Healthcare Centers
Expert Views:
The South Korea anti-infective drugs market is expected to witness sustainable long-term growth driven by increasing infectious disease treatment demand, rising antimicrobial resistance concerns, and expanding investments in advanced pharmaceutical manufacturing technologies. The integration of AI-powered antimicrobial drug discovery systems, precision diagnostics platforms, biologics production technologies, and smart pharmaceutical manufacturing architectures is anticipated to improve treatment effectiveness and strengthen long-term demand across hospitals, specialty healthcare ecosystems, infectious disease management programs, and advanced therapeutic infrastructures in South Korea.
Author: Govind and Krishna By Spherical Insights and Consulting